NCT03649464 2022-10-07Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsOblato, Inc.Phase 1/2 Withdrawn
NCT01740570 2018-01-19Phase I/II Cabazitaxel for Recurrent Malignant GliomaM.D. Anderson Cancer CenterPhase 1/2 Withdrawn